Menu
Search
|

Menu

Close
X

Jiangsu Hengrui Medicine Co Ltd 600276.SS (Shanghai Stock Exchange)

78.60 CNY
+0.51 (+0.65%)
As of Sep 12
Previous Close 78.09
Open 78.48
Volume 12,369,321
3m Avg Volume 18,414,875
Today’s High 78.95
Today’s Low 77.58
52 Week High 81.25
52 Week Low 41.48
Shares Outstanding (mil) 2,816.88
Market Capitalization (mil) 168,815.80
Forward P/E 59.17
Dividend (Yield %) 0.11 ( 0.19 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.67 Mean rating from 27 analysts

KEY STATS

Revenue (mm, CNY)
FY19
10,026
FY18
17,418
FY17
13,836
FY16
11,094
EPS (CNY)
FY19
0.540
FY18
0.925
FY17
0.733
FY16
0.590
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
59.17
32.66
Price to Sales (TTM)
vs sector
13.88
7.91
Price to Book (MRQ)
vs sector
12.34
5.38
Price to Cash Flow (TTM)
vs sector
--
24.36
Total Debt to Equity (MRQ)
vs sector
0.00
14.55
LT Debt to Equity (MRQ)
vs sector
0.00
10.20
Return on Investment (TTM)
vs sector
23.31
14.48
Return on Equity (TTM)
vs sector
23.04
15.78

EXECUTIVE LEADERSHIP

Piaoyang Sun
Chairman of the Board, Since 2003
Salary: --
Bonus: --
Xinhua Jiang
Vice Chairman of the Board, Since
Salary: --
Bonus: --
Song Zhou
Chief Financial Officer, Since 2014
Salary: --
Bonus: --
Yunshu Zhou
General Manager, Director, Since 2003
Salary: --
Bonus: --
Sumei Jiang
Executive Deputy General Manager, Director, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No.7 Kunlunshan Road
Lianyungang Eco & Tech Developme
LIANYUNGANG   JNG   222000

Phone: +86518.81220983

JIANSU HENGRUI MEDICINE CO., LTD. is a China-based company, principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.

SPONSORED STORIES